Skip to main content
. 2024 Mar 1;24:81. doi: 10.1186/s12883-024-03585-4

Table 2.

Trial primary effectiveness outcomes

Primary effectiveness outcomes Clopidogrel with Aspirin (n = 93) Clopidogrel with Indobufen (n = 89) Effect Variable Value (95% CI) p
Ending event(%) 6(6.5) 0(0) Hazard ratio 0.94(0.89–0.99) 0.029
Modified Rankin scale score at 90 days - IQR 1(1–2) 0(0–0) Common odds ratio 3.629(1.874–7.036) < 0.0001